Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about EDIT

Recent news which mentions EDIT

< Previous 1 2 3 4 5 6 7 8 9 Next >
Expert Outlook: Editas Medicine Through The Eyes Of 7 Analysts
Tickers EDIT
Tags BZI/AAR Benzinga Analyst Ratings
From Benzinga
Where Editas Medicine Stands With Analysts
Tickers EDIT
Tags Analyst Ratings Market News EDIT
From Benzinga
Looking for Stock Bargains With Room to Run? Try This.
Tickers AAPL AMZN BJRI CBRL
Tags SABR JACK CBRL
From Motley Fool
Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday
Tickers BMBL BOOT CENTA CRL
Tags analyst forecasts BOOT DIS
From Benzinga
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
Tickers CRSP EDIT NTLA
Tags NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:NTLA EDIT CRSP
From InvestorPlace
3 Profitable CRISPR Stocks Earning Analysts’ Praise
Tickers CRSP EDIT NTLA
Tags CRSP EDIT NTLA
From InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
Tickers CRSP EDIT GNOM ILMN
Tags EDIT GNOM NASDAQ:NTLA,NASDAQ:EDIT,NASDAQ:GNOM,NASDAQ:NTRA,NASDAQ:MRNA,NASDAQ:CRSP,NASDAQ:MYGN,NASDAQ:ILMN
From InvestorPlace
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
Tickers CRSP EDIT NLTA
Tags Stocks to Buy Market News NLTA
From InvestorPlace
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
Tickers CRSP EDIT NTLA
Tags EDIT NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:NTLA CRSP
From InvestorPlace
Unveiling 5 Analyst Insights On Editas Medicine
Tickers EDIT
Tags BZI/AAR Benzinga Analyst Ratings
From Benzinga
The Analyst Verdict: Editas Medicine In The Eyes Of 4 Experts
Tickers EDIT
Tags Analyst Ratings Market News EDIT
From Benzinga
Overlooked and Undervalued: 3 Stocks With Jaw-Dropping Upside Potential
Tickers CNXC EDIT Z
Tags NASDAQ:Z,NASDAQ:EDIT,NASDAQ:CNXC CNXC Z
From InvestorPlace
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
Tickers C EDIT
Tags C Market News EDIT
From Motley Fool
EDIT Stock Earnings: Editas Medicine Misses EPS, Misses Revenue for Q1 2024
Tickers EDIT
Tags Earnings Reports Market News EDIT
From InvestorPlace
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
Tickers EDIT
Tags Recent Press Releases Market News EDIT
From Motley Fool
1 Beaten-Down Stock With 55% Upside, According to Wall Street
Tickers EDIT
Tags Market News EDIT Recent Press Releases
From Motley Fool
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
Tickers C EDIT VRTX
Tags Market News C EDIT
From Motley Fool
The Latest Analyst Ratings For Editas Medicine
Tickers EDIT
Tags EDIT Market News Analyst Ratings
From Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Tickers AAP ACMR ADIL ADT
Tags FLYW M VIPS
From Benzinga
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
Tickers AAP ACMR ADT ADY
Tags Small Cap big gainers Trading Ideas
From Benzinga
Earnings Outlook For Editas Medicine
Tickers EDIT
Tags Benzinga Market News Earnings
From Benzinga
2 Under-the-Radar Stocks With Incredible Upside Potential
Tickers EDIT RXRX
Tags Recent Press Releases EDIT RXRX
From Motley Fool
Could Editas Medicine Become the Next CRISPR Therapeutics?
Tickers CRSP EDIT
Tags Market News EDIT Recent Press Releases
From Motley Fool
7 Mighty Healthcare Stocks Changing the Game of Medicine
Tickers ASXC EDIT HOLX ILMN
Tags NASDAQ:ILMN,NASDAQ:HOLX,NASDAQ:HOLX,NASDAQ:MRNA,NASDAQ:EDIT,NASDAQ:VERV,NYSEAMERICAN:ASXC HOLX EDIT
From InvestorPlace
Down 88%, Could Editas Medicine Be a Good Investment Now?
Tickers CRSP EDIT VRTX
Tags Recent Press Releases CRSP VRTX
From Motley Fool
3 Stocks to Buy in the Booming Field of Gene Editing
Tickers BEAM EDIT LLY VERV
Tags EDIT NASDAQ:EDIT,NASDAQ:VRTX,NASDAQ:BEAM,NASDAQ:VERV,NYSE:LLY VERV
From InvestorPlace
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
Tickers EDIT NTLA
Tags Recent Press Releases NTLA EDIT
From Motley Fool
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
Tickers EDIT VRTX
Tags EDIT Market News Recent Press Releases
From Motley Fool
Vertex’s stock heads for all-time high as non-opioid painkiller shows promise
Tickers EDIT SPX VRTX VTRS
Tags VTRS VRTX SPX
From MarketWatch
The Latest Analyst Ratings for Editas Medicine
Tickers EDIT
Tags EDIT Analyst Ratings Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.